ArticleBritish journal of cancer2018

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.

Marie Viala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.